NP
Nippon Shinyaku Co., Ltd.
NPPNY · OTC
$5.46 +8.12% (+$0.41)
1M +2.82%
Market Cap ¥231.7B
P/E Ratio 7.22x
Div. Yield 3.24%
ROE 11.36%
Bulios Fair Price
$7.97
46.0% upside
Current Price
$5.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NPPNY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 7.22x
PEG 0.27x
EV/EBITDA 3.87x
Growth
67 /100
Growing EPS growth 9.22%
Book val. growth 11.01%
Rev. growth 5.24%
Profitability
83 /100
Strong Gross margin 65.32%
FCF margin 10.55%
Net margin 17.51%
Quality
55 /100
Average ROIC 9.02%
Asset turnover 0.53x
ROE 11.36%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -1.66x
Current ratio 4.66x
Stability
86 /100
Stable Beta -0.32x
Profitable years 6
Rev. volatility 2.65%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NPPNY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Toru Nakai
Employees
2,309
Headquarters
Kyoto
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
07 DEC
Dividend Payment
Payment date